Q8NA77
Gene name |
TEX19 |
Protein name |
Testis-expressed protein 19 |
Names |
|
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:400629 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8NA77
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8NA77-F1 | Predicted | AlphaFoldDB |
133 variants for Q8NA77
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs761018318 CA295189559 |
4 | P>A | No |
ClinGen Ensembl |
|
|
rs371327683 CA8856379 |
4 | P>L | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA295189573 rs900962762 |
6 | S>G | No |
ClinGen Ensembl |
|
|
CA401587913 rs1245990387 |
6 | S>R | No |
ClinGen gnomAD |
|
|
CA401587930 rs1338083277 |
7 | M>I | No |
ClinGen TOPMed gnomAD |
|
|
CA8856381 rs757728929 |
7 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856383 rs143841873 |
8 | R>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs143841873 CA8856382 |
8 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs868177850 CA295189588 |
8 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
rs766491977 CA295189613 |
9 | Y>* | No |
ClinGen Ensembl |
|
|
rs1599669527 CA401587974 |
10 | E>D | No |
ClinGen Ensembl |
|
|
rs1485404930 CA401587959 |
10 | E>K | No |
ClinGen gnomAD |
|
|
rs754747769 CA8856384 |
11 | E>K | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs1352979376 CA401588005 |
12 | E>A | No |
ClinGen gnomAD |
|
|
CA8856386 rs138453353 |
15 | S>C | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA401588051 rs138453353 |
15 | S>Y | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs146250166 CA8856389 |
19 | A>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA401588143 rs1304150565 |
21 | W>* | No |
ClinGen gnomAD |
|
|
CA295189649 rs185078297 |
22 | M>I | No |
ClinGen 1000Genomes TOPMed gnomAD |
|
|
rs1395764523 CA401588157 |
22 | M>T | No |
ClinGen TOPMed |
|
|
rs141219054 CA8856391 CA8856390 |
23 | Y>* | No |
ClinGen ESP ExAC gnomAD |
|
|
rs559085175 CA295189682 |
26 | Q>R | No |
ClinGen Ensembl |
|
|
rs1318138374 CA401588243 |
27 | H>Q | No |
ClinGen gnomAD |
|
| TCGA novel | 28 | G>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs375937908 CA8856397 |
34 | C>* | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs150740969 CA8856395 |
34 | C>Y | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA8856398 rs367711836 |
35 | F>S | No |
ClinGen ESP ExAC gnomAD |
|
|
CA401588345 rs1257967420 |
37 | C>S | No |
ClinGen gnomAD |
|
|
rs1346035716 CA401588355 |
38 | F>L | No |
ClinGen gnomAD |
|
|
rs768068418 CA8856399 |
40 | A>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA401588389 rs768068418 |
40 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 40 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1259349893 CA401588404 |
41 | A>S | No |
ClinGen gnomAD |
|
|
CA401588411 rs1185108733 |
41 | A>V | No |
ClinGen Ensembl |
|
|
rs559280155 CA295189784 |
44 | D>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856403 rs559280155 |
44 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs747835900 CA8856404 |
47 | D>E | No |
ClinGen ExAC gnomAD |
|
|
CA8856406 rs116114329 |
50 | E>A | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA401588557 rs1156477833 |
50 | E>D | No |
ClinGen gnomAD |
|
|
CA8856407 rs777443933 |
52 | E>D | No |
ClinGen ExAC gnomAD |
|
|
rs746814720 CA8856408 |
53 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs553772038 CA8856409 |
54 | W>* | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA401588623 rs1599669625 |
55 | E>K | No |
ClinGen Ensembl |
|
|
CA401588706 rs1370982897 |
59 | W>* | No |
ClinGen gnomAD |
|
|
CA401588709 rs1385130699 |
60 | D>N | No |
ClinGen gnomAD |
|
|
CA401588721 rs1331784175 |
61 | P>R | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 62 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1238536426 CA401588727 |
62 | E>G | No |
ClinGen gnomAD |
|
|
CA401588731 rs1266481991 |
63 | L>M | No |
ClinGen gnomAD |
|
|
CA401588743 rs1237394406 |
64 | M>V | No |
ClinGen TOPMed |
|
|
CA401588778 rs1335076626 |
66 | H>N | No |
ClinGen TOPMed |
|
|
CA8856412 rs769889679 |
66 | H>Q | No |
ClinGen ExAC gnomAD |
|
|
rs775496340 CA8856413 |
67 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs1467122406 CA401588819 |
69 | A>T | No |
ClinGen gnomAD |
|
|
CA8856414 rs763172270 |
72 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA295189871 rs1024891723 |
73 | Q>* | No |
ClinGen Ensembl |
|
|
rs1179154699 CA401588865 |
75 | G>A | No |
ClinGen gnomAD |
|
|
CA401588866 rs1179154699 |
75 | G>V | No |
ClinGen gnomAD |
|
|
CA401588868 rs1459153804 |
76 | S>A | No |
ClinGen gnomAD |
|
|
CA401588870 rs1459153804 |
76 | S>T | No |
ClinGen gnomAD |
|
|
CA401588902 rs1302721754 |
78 | G>V | No |
ClinGen TOPMed |
|
|
rs1394348193 CA401588925 |
80 | E>K | No |
ClinGen gnomAD |
|
|
CA8856419 rs750913647 |
82 | S>N | No |
ClinGen ExAC gnomAD |
|
|
CA401588982 rs1390892071 |
83 | W>C | No |
ClinGen gnomAD |
|
|
CA8856420 rs761225499 |
83 | W>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA401588988 rs1286675254 CA401588989 |
84 | G>R | No |
ClinGen TOPMed gnomAD |
|
|
CA8856421 rs764863513 |
84 | G>V | No |
ClinGen ExAC gnomAD |
|
|
rs1453194833 CA401589016 |
86 | S>G | No |
ClinGen TOPMed |
|
| TCGA novel | 86 | S>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA8856422 rs752196807 |
86 | S>N | No |
ClinGen ExAC |
|
|
CA401589033 rs1228758354 |
87 | P>S | No |
ClinGen gnomAD |
|
|
rs1319739886 CA401589079 |
90 | P>H | No |
ClinGen gnomAD |
|
|
CA8856424 rs137989980 |
91 | V>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA8856425 rs777468964 |
92 | Q>H | No |
ClinGen ExAC gnomAD |
|
|
CA8856426 rs147220016 |
93 | G>W | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA295189935 rs371566517 |
94 | G>D | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs371566517 CA8856428 |
94 | G>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA295189953 rs375218867 |
98 | W>* | No |
ClinGen ESP |
|
|
rs1417528607 CA401589199 |
99 | G>E | No |
ClinGen gnomAD |
|
|
CA295189966 COSM1710911 rs140570015 |
99 | G>R | skin [Cosmic] | No |
ClinGen cosmic curated ESP |
|
rs768822950 CA8856433 |
101 | G>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856436 rs772518786 |
103 | L>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA401589248 rs1372613314 |
104 | A>E | No |
ClinGen gnomAD |
|
|
rs368255921 CA8856437 |
108 | E>K | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA295190020 rs952000817 |
113 | A>T | No |
ClinGen Ensembl |
|
|
CA401589415 rs1306907568 |
114 | G>V | No |
ClinGen gnomAD |
|
|
rs913848768 CA295190027 |
115 | L>P | No |
ClinGen TOPMed gnomAD |
|
|
CA401589455 CA401589458 rs1276102321 |
116 | D>E | No |
ClinGen TOPMed gnomAD |
|
|
rs113265042 CA8856441 |
117 | P>A | No |
ClinGen ExAC gnomAD |
|
|
rs113265042 CA8856440 |
117 | P>S | No |
ClinGen ExAC gnomAD |
|
|
rs751255303 CA8856444 |
118 | H>Q | No |
ClinGen ExAC gnomAD |
|
|
CA8856443 rs763692160 |
118 | H>Y | No |
ClinGen ExAC gnomAD |
|
|
CA401589548 rs1184019063 |
121 | P>S | No |
ClinGen gnomAD |
|
|
CA8856445 rs199751552 |
125 | W>* | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1381668950 CA401589643 |
125 | W>C | No |
ClinGen TOPMed |
|
|
rs1275880745 CA401589625 |
125 | W>R | No |
ClinGen TOPMed gnomAD |
|
|
rs1403014449 CA401589652 |
126 | P>S | No |
ClinGen TOPMed |
|
|
rs1599669794 CA401589678 |
127 | Q>L | No |
ClinGen Ensembl |
|
|
CA401589688 rs1305037364 |
128 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
| TCGA novel | 128 | E>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs781052597 CA8856446 |
128 | E>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856449 rs779957295 |
130 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs116293085 CA8856448 |
130 | V>L | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA8856447 rs116293085 |
130 | V>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA401589757 rs1479032497 |
131 | P>L | No |
ClinGen TOPMed |
|
|
rs1449938959 CA401589788 |
133 | G>D | No |
ClinGen gnomAD |
|
|
rs1445863837 CA401589832 |
135 | G>D | No |
ClinGen TOPMed |
|
|
rs200970555 CA8856453 |
135 | G>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA401589840 rs183087726 |
136 | L>F | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA8856454 rs183087726 |
136 | L>I | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA8856455 rs772130130 |
139 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs772130130 CA401589907 |
139 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856456 rs142370714 |
139 | A>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 140 | D>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1439503805 CA401589941 |
141 | W>R | No |
ClinGen TOPMed gnomAD |
|
|
CA401589983 rs1319763517 |
143 | Q>* | No |
ClinGen TOPMed |
|
|
CA401589996 rs1276048234 |
143 | Q>H | No |
ClinGen gnomAD |
|
|
rs1276472282 CA401590013 |
144 | G>A | No |
ClinGen TOPMed |
|
|
rs771614199 CA8856458 |
144 | G>C | No |
ClinGen ExAC gnomAD |
|
|
rs555486603 RCV000957697 |
147 | W>missing | No |
ClinVar dbSNP |
|
|
rs759919288 CA8856461 |
147 | W>G | No |
ClinGen ExAC gnomAD |
|
|
CA401590061 rs759919288 |
147 | W>R | No |
ClinGen ExAC gnomAD |
|
|
CA401590102 rs1187168976 |
149 | F>L | No |
ClinGen gnomAD |
|
|
rs1450163917 CA401590164 |
152 | L>I | No |
ClinGen gnomAD |
|
|
rs1172125146 CA401590178 |
153 | L>H | No |
ClinGen gnomAD |
|
|
rs535694164 CA8856463 |
154 | T>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1416340231 CA401590202 |
155 | C>* | No |
ClinGen gnomAD |
|
|
rs933781675 CA401590254 |
158 | W>* | No |
ClinGen TOPMed |
|
|
rs933781675 CA295190147 |
158 | W>C | No |
ClinGen TOPMed |
|
|
CA8856465 rs767149161 |
159 | P>S | No |
ClinGen ExAC gnomAD |
|
|
rs750280258 CA8856466 |
161 | F>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA8856467 rs755883987 |
164 | S>P | No |
ClinGen ExAC gnomAD |
|
|
CA401590351 rs1567854255 |
165 | S>W | No |
ClinGen Ensembl |
No associated diseases with Q8NA77
No regional properties for Q8NA77
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q8NA77 | |||
Functions
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| piRNA binding | Binding to a piRNA, a Piwi-associated RNA, a 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| cell differentiation | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| male gonad development | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
| male meiotic nuclear division | A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the male germline. |
| negative regulation of transposition | Any process that decreases the frequency, rate or extent of transposition. Transposition results in the movement of discrete segments of DNA between nonhomologous sites. |
| placenta development | The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. |
| reciprocal meiotic recombination | The cell cycle process in which double strand breaks are formed and repaired through a single or double Holliday junction intermediate. This results in the equal exchange of genetic material between non-sister chromatids in a pair of homologous chromosomes. These reciprocal recombinant products ensure the proper segregation of homologous chromosomes during meiosis I and create genetic diversity. |
| spermatogenesis | The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MCPPVSMRYE | EEGMSYLYAS | WMYQLQHGDQ | LSICFTCFKA | AFLDFKDLLE | SEDWEEDNWD |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PELMEHTEAE | SEQEGSSGME | LSWGQSPGQP | VQGGSEAWGP | GTLAAAPEGL | EDAGLDPHFV |
| 130 | 140 | 150 | 160 | ||
| PTELWPQEAV | PLGLGLEDAD | WTQGLPWRFE | ELLTCSHWPS | FFPS |